Video Experimental Relacionado
Updated: Jul 9, 2026
10:10
Platelet Adhesion and Aggregation Under Flow using Microfluidic Flow Cells
Published on: October 27, 2009
Efectos de las estatinas en la inhibición plaquetaria por una alta dosis de carga de clopidogrel
Iris Müller1, Felicitas Besta, Christian Schulz
1Medizinische Klinik, Klinikum rechts der Isar und Deutsches Herzzentrum, Technische Universität München, Germany.
Circulation
|October 22, 2003
Resumen
Las dosis altas de clopidogrel (600 mg) combinadas con estatinas no inhibieron los efectos antiplaquetarios. Este estudio no encontró ninguna interacción significativa entre las estatinas y el clopidogrel, lo que garantiza una inhibición plaquetaria efectiva.
Área de la Ciencia:
- Farmacología Cardiovascular Farmacología Cardiovascular
- Estudios de agregación plaquetaria Estudios de agregación plaquetaria
Sus antecedentes:
- Existen preocupaciones con respecto a los inhibidores de la estatina-HMG-CoA reductasa que podrían reducir la eficacia antiplaquetaria del clopidogrel.
- Investigar las interacciones estatina-clopidogrel es crucial para los pacientes en tratamiento antiplaquetario dual.
Objetivo del estudio:
- Para evaluar el impacto de varias estatinas en la actividad antiplaquetaria de una dosis alta de carga de clopidogrel.
- Para determinar si el uso de estatinas afecta la capacidad del clopidogrel para inhibir la agregación plaquetaria.
Principales métodos:
- Un estudio aleatorizado en el que participaron 77 pacientes con angina estable sometidos a stenting coronario.
- Los pacientes recibieron una de varias estatinas (atorvastatina, fluvastatina, lovastatina, pravastatina, simvastatina, cerivastatina) o placebo, junto con aspirina y una dosis de carga de 600 mg de clopidogrel.
- La agregación plaquetaria inducida por difosfato de adenosina (ADP) se midió al inicio y 2 y 4 horas después de la administración de clopidogrel.
Principales resultados:
- Ninguna de las estatinas analizadas demostró una influencia significativa en la inhibición de la agregación plaquetaria inducida por el clopidogrel.
- La agregación plaquetaria se mantuvo efectivamente inhibida en todos los grupos de estatinas y en el grupo de placebo.
Conclusiones:
- La administración concomitante de estatinas con una dosis de carga alta de clopidogrel (600 mg) no afecta significativamente la actividad antiplaquetaria del clopidogrel.
- Este hallazgo sugiere una coadministración segura de estos medicamentos cardiovasculares comunes.
Videos de Conceptos Relacionados
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...